This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, Scripps Research Institute. Active years: 2019.
Company Filing History:
1 out of 99 
1 out of 1,205 
Years Active: 2019
Title: The Innovations of Stefan J. Riedl
Introduction
Stefan J. Riedl is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of neuroprotection and neural repair through his innovative research and patents. His work focuses on developing therapeutic solutions for diseases and disorders related to EphA4.
Latest Patents
One of Riedl's notable patents is titled "EPHA4 cyclic peptide antagonists for neuroprotection and neural repair." This patent discloses APY cyclic peptides that exhibit EphA4 antagonistic activity. The specification details pharmaceutical compositions containing these EphA4 antagonists and outlines methods for treating EphA4-based diseases, disorders, or pathologies using these peptides or compositions. Riedl holds 1 patent in this area.
Career Highlights
Throughout his career, Riedl has worked with prestigious institutions, including the Sanford Burnham Prebys Medical Discovery Institute and The Scripps Research Institute. His research has contributed to advancements in understanding and treating neurological conditions.
Collaborations
Riedl has collaborated with notable scientists, including Elena B. Pasquale and Philip E. Dawson. These partnerships have enhanced his research and expanded the impact of his work in the scientific community.
Conclusion
Stefan J. Riedl's innovative contributions to neuroprotection and neural repair highlight his role as a leading inventor in the field. His patent on EphA4 cyclic peptide antagonists showcases his commitment to advancing medical science and improving patient outcomes.